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Abstract
Background: In previous studies using candidate gene approaches, low sperm count (oligospermia) has been associated
with altered sperm mRNA content and DNA methylation in both imprinted and non-imprinted genes. We performed a
genome-wide analysis of sperm DNA methylation and mRNA content to test for associations with sperm function.
Methods and Results: Sperm DNA and mRNA were isolated from 21 men with a range of semen parameters presenting to a
tertiary male reproductive health clinic. DNA methylation was measured with the Illumina Infinium array at 27,578 CpG loci.
Unsupervised clustering of methylation data differentiated the 21 sperm samples by their motility values. Recursively
partitioned mixture modeling (RPMM) of methylation data resulted in four distinct methylation profiles that were
significantly associated with sperm motility (P=0.01). Linear models of microarray analysis (LIMMA) was performed based
on motility and identified 9,189 CpG loci with significantly altered methylation (Q,0.05) in the low motility samples. In
addition, the majority of these disrupted CpG loci (80%) were hypomethylated. Of the aberrantly methylated CpGs, 194
were associated with imprinted genes and were almost equally distributed into hypermethylated (predominantly paternally
expressed) and hypomethylated (predominantly maternally expressed) groups. Sperm mRNA was measured with the
Human Gene 1.0 ST Affymetrix GeneChip Array. LIMMA analysis identified 20 candidate transcripts as differentially present
in low motility sperm, including HDAC1 (NCBI 3065), SIRT3 (NCBI 23410), and DNMT3A (NCBI 1788). There was a trend among
altered expression of these epigenetic regulatory genes and RPMM DNA methylation class.
Conclusions: Using integrative genome-wide approaches we identified CpG methylation profiles and mRNA alterations
associated with low sperm motility.
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Introduction
Traditional semen analysis measures sperm concentration,
motility, morphology, and semen volume, and is acknowledged
to be a poor predictor of fertility, demonstrating remarkable intra-
and inter-individual variability [1,2]. Because of these limitations,
effort has been devoted to developing sperm molecular biomarkers
that may better and more stably reflect sperm function.
DNA methylation is the stable, covalent addition of a methyl
group to cytosine that can represent response to environmental
cues or exposures that may modify gene expression. Both human
and animal studies indicate that abnormal sperm DNA methyl-
ation patterns are associated with subfertility, including aberrant
methylation of both imprinted [3–11] and non-imprinted genes
[4,12,13] in oligospermic men.
In addition to DNA methylation, significant effort is being
devoted to developing human sperm mRNAs as biomarkers of
infertility [14–30]. The discovery of mRNAs in mature sperm
shook the long-held belief that the sole purpose of sperm was to
deliver its DNA to the egg [14]. Recent evidence indicates that
some of these transcripts may be intentionally transported to the
oocyte to aid embryogenesis, since some sperm mRNAs are found
to persist in the zygote and are functionally important [14,27,28].
In addition, remnant sperm mRNAs provide a record of the
spermatogenic environment and may have clinical applications as
novel biomarkers of fertility status [15–26].
In the present study, we utilized high-density array techniques
to investigate the hypothesis that alterations to the pattern of
sperm DNA methylation or mRNA content are associated with
sperm function.
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Ethics Statement
The Committee on the Protection of Human Subjects: Rhode
IslandHospitalInstitutionalReviewBoard2 (Committee #403908)
approved the study and written informed consent was obtained
from all participants. Clinical investigation was conducted accord-
ing to the principles expressed in the Declaration of Helsinki.
Microarray DataSets
The microarray data discussed in this publication is MAIME
compliant and the raw data has been deposited in NCBI’s Gene
Expression Omnibus (Edgar et al., 2002) as detailed in the MGED
Society website http://www.mged.org/Workgroups/MAIME/
maime.html. This data is accessible through GEO Series accession
number GSE26982 (http://www.ncbi.nlm.nih.gov/geo/query/
acc.cgi?acc=GSE26982).
Patient Population, Semen Analysis, and Sperm Isolation
Study subjects presented for semen evaluation at Rhode Island
Hospital’s tertiary male reproductive health clinic. Samples were
collected from 21 men with unknown fertility status and a range of
semen characteristics (Table 1). During the semen analysis,
morphology was scored using Kruger strict criteria and total
motility was calculated as described in the WHO laboratory
manual (2010) [31].
After clinical analysis the samples were divided into one quarter
and three quarter aliquots for DNA and RNA isolations,
respectively. Each group was processed through an optimized
Percoll (GE Healthcare, Uppsala, Sweden) gradient to eliminate
debris, non-sperm cells, and dead sperm [32]. Briefly, 1 ml of the
fresh semen was applied to a monolayer of 50% Percoll. After
centrifugation, the upper and interface layers containing the dead
sperm and other somatic contaminants were aspirated off, leaving
the sperm enriched fraction. The sperm fraction was washed with
phosphate buffered saline and the purified sperm samples were
processed immediately for mRNA and DNA isolation.
Prior to processing the 21 samples, sperm purity was confirmed
by the absence of somatic cell contaminants using bright phase
microscopy and by the absence of 18/28S ribosomal RNA peaks
by RNA gel electrophoresis (data not shown) [19,21].
DNA Isolation, Bisulfite Modification, and Illumina
Infinium HumanMethylation27 BeadChip Array
DNA was isolated from the sperm of the 21 men using a
modified protocol in which sperm pellets were lysed for 16 hours
in a solution containing Tris (Fisher Scientific, Pittsburgh, PA,
USA), DTT (Promega Corporation, Madison, WI, USA), NaCl
(EMD Chemicals, Inc., the North American Affiliate of Merck
KGaA, Darmstadt, Germany), EDTA (Fisher Scientific, Pitts-
burgh, PA, USA), SDS (Fisher Scientific, Pittsburgh, PA, USA),
Proteinase K (Promega Corporation, Madison, WI, USA), and
beta-mercaptoethanol (Sigma-Aldrich, St. Louis, MO, USA) [33].
The DNA was then extracted using phenol/chloroform (Sigma-
Aldrich, St. Louis, MO, USA), ethanol precipitated, and bisulfite
modified using the EZ DNA Methylation kit (Zymo Research
Corporation, Orange, CA, USA). Genome-wide scanning for
DNA methylation was performed using the Illumina Infinium
HumanMethylation27 BeadChip assay (Illumina, Inc., San Diego,
CA, USA) to determine the methylation state at 27,578 CpG sites
spanning more than 14,000 genes; and on this array, there are 616
CpGs associated with 187 imprinted genes identified using
the array’s annotation file (HumanMethylation27_270596_v.1.2,
www.Illumina.com). Multiple groups including ours have previ-
ously demonstrated the validity of Illumina methylation array data
using several different approaches [34–39].
Imprinted Genes
A list of 187 imprinted genes in the human genome was compiled
based on information from three sources: (1) experimentally
determined imprinted genes listed in two databases (http://www.
geneimprint.com/databases/ and http://igc.otago.ac.nz/home.
html) (n=62); (2) imprinted genes identified using the ChIP-SNP
method (n=27) [40]; and (3) protein-coding genes from the 156
putatively imprinted sequences that correspond to known genes
listed by NCBI (n=106) [41]. Taken together, a final list of 187
imprinted genes is identified from these three sources (Table S1).
mRNA Isolation and Affymetrix GeneChip Human Gene
1.0 ST Array
Sperm mRNA was extracted from 18 of the 21 men using a
modified Stat 60 (IsoTex Diagnostics, Inc., Friendswood TX,
USA) protocol in addition to components of Qiagen’s RNeasy kit
(Qiagen Sciences, Germantown, MD, USA). Using the Brown
Genomics Core Facility, the isolated sperm mRNA was processed
and hybridized to Affymetrix GeneChip Human Gene 1.0 ST
Arrays (Affymetrix, Santa Clara, CA, USA), providing whole-
transcript coverage of 28,869 genes by ,26 probes spread across
the length of each gene. The probe cell intensity data from the
Affymetrix GeneChips was normalized and annotated using
Affymetrix Expression Console as recommended by the manufac-
turer. The application uses the RMA-Sketch workflow analysis as
the default to create CHP files. The CHP log2 expression files
were then merged in Expression Console with the annotation file
Table 1. Semen Parameters of Subjects Examined.
Subject ID Motility (%) Morphology (%) Count (610
6/ml)
16 77 11 132
87 4 4 . 5 1 8
26 70 6 80
56 4 8 4 4
22 64 5.5 67
29 63 7 174
35 62 8 103
13* 60 8 26
28 60 10 72
10 57 10 58
31* 57 4 30
11 52 8 49
36 51 3 44
37 49 1 9
32 46 8.5 23
23 45 1 67
33* 41 6 1.6
34 39 4 20
40 34 4 72
9 30 3.5 7
41 21 0 15
Note: Patients with * were excluded from the mRNA analysis due to low yield.
doi:10.1371/journal.pone.0020280.t001
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third-party downstream analysis.
Statistical Analyses
Aside from array normalization procedures, the R software
environment (R Foundation for Statistical Computing, Vienna,
Austria) was used for all statistical analysis.
Recursively Partitioned Mixture Modeling
Recursively partitioned mixture modeling (RPMM) profiles were
fit to the entire Infinium array using previously described methods
[42]. This method builds classes of samples based upon the
similarityofmethylationprofilesbyrecursivelysplittingsamplesinto
parsimoniously differentiated classes. The classes are identified by
pattern of branching into right (R) or left (L) arms. Permutation tests
Figure 1. Unsupervised clustering of the 1,000 most variable CpG loci average beta values. The dendrograms above the heatmap show
unsupervised clustering based on the methylation data alone, using a Euclidean metric with Ward’s method of hierarchical clustering. Patients are
represented by column (n=21) and CpG loci (n=1000) by row. Each cell represents the CpG level of methylation for one site in one sample. The
methylation scale indicates the level of methylation: yellow=sample predominantly unmethylated (0–49% methylated); black=50% of the sample is
methylated; blue=sample predominantly methylated (51–100%). The column annotation track shows motility: orange=low, purple=high.
doi:10.1371/journal.pone.0020280.g001
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were used to test associations between RPMM class and the 3
clinical fertility variables: count, motility and morphology, using the
valuesinTable1.Ourteststatisticwasthemaximumofthe KWtest
statistic, and the null distribution for this test statistic was obtained
by the permutation. Semen parameters were considered signifi-
cantly associated with RPMM profiles when P,0.02, after
Bonferroni correction for multiple comparisons.
Quantitative Analysis of the DNA Methylation Status of
All CpGs
The LIMMAprocedure [43] (R packagelimma)utilized a matrix
design containing the 21 samples and their corresponding percent
motility values listed in Table 1 to fit a simple linear regression
model for each CpG dinucleotide. This univariately tests each CpG
for association between methylation and sperm motility. LIMMA
results provided estimates of strength and direction of association
Figure 2. Heatmap displaying the methylation status of CpG loci related to known and predicted imprinted genes. The dendrograms
above the heatmap show unsupervised clustering based on the methylation data alone, using a Euclidean metric with Ward’s method of hierarchical
clustering. Patients are represented by column (n=21) and CpG loci by row (n=616). Each cell represents the CpG level of methylation for one site in
one sample. The methylation scale indicates the level of methylation: yellow=sample predominantly unmethylated (0–49% methylated); black=50%
of the sample is methylated; blue=sample predominantly methylated (51–100%). The column annotation track shows motility: orange=low,
purple=high. The row annotation track shows type of imprinting: pink=maternally expressed, light blue=paternally expressed, light green=not
determined.
doi:10.1371/journal.pone.0020280.g002
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multiple comparisons withthe qvalue package in R [44]. CpGs with
positive slopes were interpreted as hypomethylated in low motility
sperm and CpGs with negative slopes were interpreted as
hypermethylated in low motility sperm.
mRNA Content Analysis of Candidate Transcripts
The transcript presence of the 276 candidate genes was tested
using the same statistical strategy as the CpG analysis except here
the design matrix was limited to the 18 samples with array data
and the slopes were transformed into fold change values. The
Affymetrix platform yielded a dataset with ,28,000 transcripts to
assess. However, sperm contain a limited transcriptome (,5000
transcripts) with few (,400) consistently expressed in sperm [22].
Therefore, we assessed 276 genes where an a priori hypothesis for
association with subfertility existed based on previous reports. The
analysis included 177 imprinted genes (10 of the 187 potential
imprinted genes were not present on the Affymetrix array) as well
as 99 candidate genes with biallelic expression (Table S1 and
Table S2) [10,11,13,24,26,29,45–49].
Statistical Analysis Comparing Associations Among
RPMM Classes and Candidate Genes
Associations among the RPMM classes and the normalized
gene expression values for candidate transcripts were calculated
with the KW test statistic utilizing the strategy employed
previously. Messenger RNAs were considered significantly associ-
ated with RPMM class when P,0.02, after adjusting for multiple
comparisons using the Bonferroni correction.
Results
Sperm DNA Methylation Profiles Cluster by Motility
Unsupervised clustering of sperm DNA methylation data for the
1,000 most variable CpG loci on the array highlights the
methylation differences among the 21 individual men (Figure 1).
As shown in the column annotation track, the clustering
differentiated men based upon the motility of their sperm, with
high motility samples (dark purple) clustering together and low
motility samples (dark orange) clustering together, with interme-
diate shades between. The DNA methylation of CpGs within
imprinted genes is established during spermatogenesis and
maintained in mature spermatozoa. In addition, several labora-
tories have shown alterations at imprinted loci to occur more
frequently in men with sperm abnormalities [3–8,10,11]. Thus, we
hypothesized that imprinted loci may be specifically targeted for
aberrant methylation in low motility sperm and separately
clustered the 616 CpG loci associated with the 187 imprinted
genes present on the array. We observed the same overall trend,
with high motility samples clustering together and low motility
samples clustering together (Figure 2).
Sperm DNA Methylation Profiles are Significantly
Associated with Motility
Recursively partitioned mixture modeling (RPMM) was per-
formed on raw methylation data to organize the sperm samples
into methylation classes based on similarity. The algorithm first
separated the 21 sperm profiles into two different branches left (L)
and right (R) and then further subdivided each branch into right
and left branches resulting in 4 total classes: left left (LL), left right
(LR), right left (RL) and right right (RR) (Figure 3, A). In Figure 3
(B) we plotted methylation class-specific sperm motility values:
samples in methylation class RR had the lowest median motility,
and methylation class was significantly associated with motility
after adjusting for multiple comparisons (P=0.01). The association
between RPMM methylation class and sperm morphology
approached statistical significance (P=0.09), though methylation
class was not associated with sperm count (P=0.29).
Thousands of CpG Loci are Significantly Altered in Low
Motility Sperm
Linear models of microarray analysis (LIMMA) was used to
univariately test each CpG for association with motility. 9,189 of
27,578 CpGs (34%) had significantly altered methylation associated
Figure 3. RPMM classes. (A) RPMM displaying 1,000 most variable
CpGs by class. Each column represents a class generated by RPMM (left
left (LL), left right (LR), right left (RL), and right right (RR)). The width of
the column represents the number of patients distributed in that class.
The rows represent the average beta values for each CpG within the
class. The methylation scale indicates the level of methylation:
yellow=sample predominantly unmethylated (0–49% methylated);
black=50% of the sample is methylated; blue=sample predominantly
methylated (51–100%).(B) Boxplot comparing the motility values for
each class.
doi:10.1371/journal.pone.0020280.g003
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S3). Of these, 1,827 CpGs (20%) were hypermethylated in the low
motility samples, whereas 7,362 CpGs (80%) were hypomethylated.
Because establishing proper methylation marks within imprinted
genes during spermatogenesis is critical, we next restricted our
analysis to CpGs associated with imprinted genes. Of the 616 CpGs
associated with imprinted genes, 194 CpGs (31.5%) had significant
associations with motility, similar to the distribution of the array
overall. Amongst these loci, 47% (n=92) were hypermethylated in
the low motility samples, whereas 53% (n=102) were hypomethy-
lated. The majority of hypomethylated CpGs were on maternally
expressed genes (45%), followed by paternally expressed (33%) and
those with undetermined parent of expression (22%). Conversely,
the majority of hypermethylated CpGs were associated with
paternally expressed genes (70%), with the remainder maternally
expressed (26%), and of undetermined parental expression (4%).
The 194 loci corresponded to 92 genes, with 11 genes showing both
hyper- and hypomethylated loci (Table 2).
Aberrant promoter methylation in genes related to spermato-
genesis and epigenetic regulation have recently been identified in
sperm from men with poor semen quality [3–13] Thus, we next
performed an analysis restricted to array CpGs associated with
genes related to spermatogenesis and epigenetic regulation. Of the
147 CpGs on the array associated with genes involved in
spermatogenesis, 39% (n=58) were significantly altered in low
motility sperm (similar to the 34% of CpGs associated with low
motility in array-wide tests, Table 2). Among these 58 CpG loci,
71% (n=41) were hypomethylated and 29% (n=17) were
hypermethylated in low motility samples. There were 50 CpG loci
associated with epigenetic regulatory genes identified on the array,
and only 26% (n=13) had significantly altered methylation in low
motility sperm samples. Of these, 61.5% (n=8) were hypomethy-
lated and 38.5% (n=5) were hypermethylated (Table 3).
mRNA Content is Altered in Low Motility Sperm
Focusing on imprinted mRNAs and candidate biallelic mRNAs,
LIMMA analysis was performed to identify differentially expressed
transcripts, conditioning on motility. Twenty genes were identified
as significant after adjusting for false discovery rate (Q,0.05)
(Table S4). These included 11 imprinted genes (GLI3 (NCBI
2737), APAB1 (NCBI 320), CTNND2 (NCBI 1501), FERMT2
(NCBI 10979), PHPT1 (NCBI 29085), SNRPN (NCBI 6638),
PPP1R9A (NCBI 55607), CDH18 (NCBI 603019), ALDH1L1
(NCBI 10840), LDB1 (NCBI 8861), and PEX10 (NCBI 5192)), six
Table 2. Imprinted Genes with Aberrant DNA Methylation.
Known Imprinted Predicted Imprinted
Gene E # MS Gene E # MS Gene E # MS Gene E # MS
BMPR2 N1 2 MAPK12 N22 ALDH1L1 M1 2 LMX1B M1 2
CCNE1 N1 2 MEG3* M3 + ANKRD11 M2 2 LY6D P2+
CD44 N2 2 MEST* P32/+ APBA1 P22 MYEOV2 P12
CDKN1C M3 2 MKRN3 P1+ BRP44L P12 OTX1 M2 2
COPG2 P2 2 NDN P3+ COL9A3 M2 2/+ PEX10 M2 2/+
CTAG2 N2 + NEDD9 N12 DVL1 M1 2 PHPT1 M1 2
CTNND2 N1 2 NGFB N12 EGFL7 P22 PPAP2C M2 +
CYR61 N1 2 NNAT P5+ FAM59A P22 PRDM16 P12
DIRAS3* P1 1 + PCNA N22 FAM70B M1 2 PTPN14 M1 2
DLK1 P1 + PEG10 P82/+ FASTK M1 2 PURG P22
DLX5 M3 2/+ PHLDA2 M4 2 FOXF1 M1 2 PYY2 P2+
GABRA5 P1 2 PLAGL1* P5+ GATA3 P12 RPL22 P12
GFI1 P1 2 SDHD P1+ HES1 P12 SALL1 M1 2
GRB10 N5 2/+ SGCE P2+ HIST3H2BB M1 2 SLC4A2 P22
H19* M4 2/+ SHANK2 M1 2 HOXA11 M1 2 SOX8 P12
HYMAI P1 2 SLC22A18 M7 2/+ HOXA5 M1 + TIGD1 P12
IGF2* P1 2 SNRPN* P6+ HOXB2 M1 2 TMEM60 P22
IGF2AS P4 2 TCEB3C M3 + HOXB3 M1 + VAX2 M1 2
IL1B N2 2 TP73 M2 2/+ HOXC4 M1 2 WDR8 M1 2
ILK N2 2 UBE3A M1 2 HSPA6 M1 + ZFP36L2 M1 2
KCNQ1DN M2 + WT1 P92/+ IFITM1 M1 2 ZNF550 P12
L3MBTL P2 + ZIM2 P5+ LDB1 M1 2
LASS4 N2 2 ZNF264 M3 2/+
LMO1 N1 2 ZNF331 P12
MAGEL2 P3 +
Note: E=parent with expressed allele; #=number of significantly altered loci in low motility samples; MS=methylation status of the loci; M=maternally expressed;
P=paternally expressed; N=parent of origin not determined; 2=loci hypomethylated in low motility samples; +=loci hypermethylated in low motility samples; 2/+=more
thantwolociwerealteredandsomeofthelociwerehypomethylatedandsomeofwerehypermethylated.Geneswith*havebeenpreviouslyreporteddifferentiallymethylated
in sperm.
doi:10.1371/journal.pone.0020280.t002
Sperm DNA Methylation and mRNA Content Analyses
PLoS ONE | www.plosone.org 6 June 2011 | Volume 6 | Issue 6 | e20280genes associated with spermatogenesis (SERPINA5 (NCBI 5104),
ACE (NCBI 1636), FANCC (NCBI 2176), PCSK4 (NCBI 57460),
CYP19A1 (NCBI 1588), and FAS (NCBI 355)), and three
epigenetic regulatory genes (HDAC1, DNMT3A, and SIRT3).
HDAC1, DNMT3A, LDB1 and FAS showed increased mRNA
content in the low motility samples, whereas the remaining 16
showed decreased mRNA content.
Integration of Epigenetic and Transcript Data
It is known that major modifications in chromatin organization
occur in spermatid nuclei during spermatogenesis, leading to the
high degree of packaging in the sperm head. Chromatin
compaction ensues when the histones surrounding the DNA are
replaced by protamines, and this occurs in parallel with
transcriptional arrest [45]. Therefore, nuclear packaging and
transcript content are interrelated. To determine whether altered
expression of epigenetic regulatory genes was associated with
methylation profiles we plotted the methylation class-specific gene
expression values for the three epigenetic regulatory genes
(HDAC1, SIRT3, and DNMT3A) with significantly altered
expression in low motility sperm (Figure 4). Among methylation
classes, expression values for HDAC1, SIRT3, and DNMT3A were
most altered in class RR, the class with lowest motility sperm
(increased expression for HDAC1 and DNMT3A, and decreased
expression for SIRT3). For all three genes, the association between
mRNA expression level and methylation class membership
approached significance after adjusting for multiple comparisons
(HDAC1, P=0.03; SIRT3, P=0.06; and DNMT3A, P=0.07).
Figure 4. Boxplots comparing DNA methylation profiles and gene expression values for the 3 epigenetic regulators. Each panel of
boxplots (A–C) compares expression data for a particular gene: (A) HDAC1; (B) SIRT3; and (C) DNMT3A. The x-axis represents RPMM classes. The y-axis
represents normalized gene expression values (NEV).
doi:10.1371/journal.pone.0020280.g004
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Currently, the evaluation of male infertility relies upon physical
exam and semen and hormone analyses; although quick and
relatively inexpensive, these physiologic measurements often do
not explain the underlying cause of infertility nor predict the
usefulness of various therapeutic interventions. Therefore, new
approaches are needed to identify the etiologies of male infertility.
Recent data suggest that sperm DNA methylation abnormalities
and alterations in sperm mRNA content are found in infertile men
[3–8,10,11,13–30,50]. Here we extend these studies by performing
integrative analysis of sperm DNA methylation and mRNA
content using genome-wide approaches to identify significant
associations among these profiles and semen parameters.
Due to the unreliable nature of classifying men into abnormal
and normal groups during a semen analysis, we used a data driven
approach to first qualitatively assess associations among sperm
DNA methylation and our patient population. Unsupervised
clustering indicated that there was an association between DNA
methylation and motility status. This was true both for all of the
CpGs on the array and the imprint-only subset.
RPMM separated the 21 men into four classes based on
similarity of DNA methylation array data. The median motility
values were calculated for each class and the results suggested that
the methylation profiles were associated with motility. Comparing
the DNA methylation heatmap to the class versus motility boxplot
indicates that the low motility class has the most aberrantly
methylated CpGs. Overall, these data suggest that low motility
sperm have increased hypomethylation relative to high motility
sperm. We used LIMMA to identify the significantly altered CpGs
conditioned on changes in motility for all CpGs on the array: over
one-third of the CpGs (and almost half of the genes represented on
the array) were significantly differentially methylated in the low
motility samples and the majority of these were hypomethylated.
The high prevalence of aberrantly methylated CpGs suggests a
genome-wide DNA methylation defect in the low motility sperm.
It has been previously hypothesized that the aberrant sperm DNA
methylation could be due to abnormal chromatin compaction,
inefficient DNA methyltransferases, and/or failure to maintain or
acquire the correct methylation marks during spermatogenesis and
our results are consistent with this literature [11–13,29].
We initially focused on CpGs mapping to imprinted genes
because of their plasticity during spermatogenesis, biological
relevance following conception and development, and because
previous studies have identified imprinted loci as aberrantly
methylated in abnormal sperm [3–8]. In our data, the distribution
of significantly hyper- and hypomethylated imprinted loci was
nearly equal. Expanding the imprinting analysis to the gene level
identified 92 genes with altered CpG methylation, seven of which
(DIRAS3 (NCBI 9077), H19 (NCBI 283120), IGF2 (NCBI 3481),
MEST/PEG1 (NCBI 4232), PLAGL1/ZAC (NCBI 5325), MEG3/
GTL2 (NCBI 55384), and SNRPN) have already been noted as
aberrantly methylated in abnormal sperm [3–8,10,11]. The
methylation status of two genes, (PEG3 (NCBI 5178) and LIT1/
KCNQ1OT1 (NCBI 10984)) has been inconsistently reported in the
literature [3,8,10]. We observed no statistical differences for these
genes between the low and high motility sperm, which is consistent
with the results published by Sato, et al. [10]. In fact, our study
confirmed all of the DNA methylation results reported in the
aforementioned study.
To further clarify the potential functional alterations to
imprinted genes and critical epigenetic regulatory genes, we
evaluated sperm mRNA content of 177 imprinted genes and 99
other transcripts where an a priori hypothesis for association with
male subfertility or epigenetic regulation exists. Twenty genes were
identified as demonstrating significantly altered transcript levels in
low motility sperm. All of the mRNAs except HDAC1, DNMT3A,
LBD1, and FAS were present in decreased amounts in low motility
sperm, and we did not observe altered mRNA content for BRDT,
which was previously reported to have increased expression in
subfertile patients [29].
Integration of epigenetic and expression data revealed a
relationship between transcript content of three epigenetic
regulatory genes (HDAC1, SIRT3, and DNMT3A) and methylation
class. HDAC1 is the predominant histone deacetylase (HDAC)
during spermatogenesis. Histone hyperacetlyation is required for
the histone to protamine exchange and is facilitated by the
degradation of HDAC1 in elongated spermatids [51]. If HDAC1
Table 3. Genes Associated with Spermatogenesis and Epigenetic Regulation with Aberrant DNA Methylation.
Gene # MS Gene # MS Gene # MS Gene # MS
ADAM2 1 + CSF1 2 2 KIT 1 2 SIRT5 1 2
ADAMTS2 1 2 CTCF 1 2 LIMK2 1 2 SIRT7 2 2
AR 4 2/+ CTCFL 1 + MLH1 2 + SLC12A2 1 2
ATM 5 2/+ DAZL* 1 + MORC1 2 + SPO11 2 +
BCL2 2 2/+ DDX4 1 + MSH5 1 2 STRBP 1 2
BCL2L2 1 2 DHH 1 2 MTHFR* 1 + STYX 1 2
BCL6 2 2 DMC1 1 2 PCSK4 1 2 SYCP3 2 +
BRDT 1 + DNMT3A 1 2 PIK3CG 1 2 TBPL1 1 2
BMP8B 1 + DNMT3B 1 + PMS2 2 2 TERT 1 2
BSG 1 2 EGR4 2 2/+ RXRB 1 2 TUSC2 2 2
CCNA1 1 2 HCLS1 1 2 SIAH1 2 2 VDAC3 1 +
CDKN2C 1 2 HDAC2 1 2 SIRT1 2 2/+
CREM 2 2 INPP5B 1 2 SIRT2 1 2
Note: #=Number of significantly altered loci in low motility samples; MS=methylation status of the loci; 2=loci hypomethylated in low motility samples; +=loci
hypermethylated in low motility samples; 2/+=more than two loci were altered and some of the loci were hypomethylated and some of were hypermethylated. Genes
with * have been previously reported differentially methylated in sperm.
doi:10.1371/journal.pone.0020280.t003
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replaced by protamines, leading to an ‘‘immature’’ sperm
chromatin structure, with less compact DNA. Therefore, incom-
plete or incorrect nuclear compaction may influence overall sperm
maturation and be reflected in the physiological endpoint of
motility.
SIRT3 is a class III histone deacetylase and this HDAC family is
similar to the yeast Sir2 protein which has been associated with
chromatin silencing and also plays roles in cellular metabolism and
aging [46]. In mammals, however, SIRT3 is targeted to the
mitochondria and functions to induce the expression of the
antioxidant MnSOD to eliminate reactive oxygen species (ROS)
generated during oxidative phosphorylation [52]. Recent studies
have found that increased ROS in sperm have deleterious effects
on sperm motility parameters which ultimately have adverse
effects on fertility [53]. Therefore, the decrease in SIRT3 mRNA
in the low motility sperm may reflect reduced MnSOD and
increased intracellular ROS during spermatogenesis, leading to a
diminished fertility potential.
The literature also suggests that oxidative stress itself can
impede the process of DNA methylation, resulting in a
hypomethylated phenotype [54]. Interestingly, we observed global
hypomethylation in the low motility sperm even though we saw
increased DNMT3A transcript presence in the low motility sperm.
Because DNMT3A is the DNA methyltransferase responsible for
de novo methylation, our data suggests a failure of the low motility
sperm to acquire the proper methylation patterns.
Although we were limited by sample size, we used a powerful
integrative approach to simultaneously examine sperm DNA
methylation and mRNA content utilizing two high density array
techniques. We found that: (1) low motility sperm have genome-
wide DNA hypomethylation that may be due to a failure of the
sperm to complete chromatin compaction properly because of
increased HDAC1 presence; (2) low motility sperm have reduced
SIRT3 mRNA content which might be related to increased
subcellular ROS during spermatogenesis leading to the abnormal
motility phenotype; and (3) this oxidative stress may be impeding
the ability of DNMT3A to set the correct methylation marks
which would also contribute to the hypomethylated phenotype.
Our results suggest that additional integrative studies including
larger sample sizes as well as prospective studies of fertility
following these integrated molecular assessments have great
potential to advance our understanding of the molecular features
of sperm associated with fertility status.
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